GlassScriptPhysician profile
Wesley M Fiser
NPI 1124317854
$3,161.32
in general payments reported to CMS, 2019-2025
28 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $568 · 2020: $574 · 2021: $585 · 2022: $824 · 2023: $228 · 2024: $203 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $910.51 | 2019-2025 | |
| Amgen INC. | $268.24 | 2019-2021 | |
| Abbott Laboratories | $201.72 | 2019-2025 | Cardiomems |
| Boston Scientific Corporation | $190.12 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $184.04 | 2021-2024 | Camzyos, Eliquis |
| Heartflow, INC. | $157.72 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $132.62 | 2021-2023 | Verquvo |
| Medtronic, INC. | $130.15 | 2022 | |
| Philips North America LLC | $114.43 | 2020-2025 | Ecc Solutions, Extended Holter |
| Medtronic Vascular, INC. | $113.37 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $103.51 | 2019-2022 | |
| Pfizer INC. | $101.39 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $74.61 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $72.82 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $63.26 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $56.88 | 2019-2022 | |
| Baxter Healthcare | $51.17 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Irhythm Technologies, INC. | $36.18 | 2024 | Zio Monitor, Zio Xt Patch |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.69 | 2021 | |
| Esperion Therapeutics, INC. | $26.14 | 2020 | |
| Abiomed | $26.07 | 2022 | |
| Edwards Lifesciences Corporation | $19.00 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Atricure, INC. | $18.17 | 2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Lundbeck LLC | $17.71 | 2020 | |
| Cardiva Medical, INC. | $17.48 | 2025 | Cardiva Vascade 6/7f Vcs |
| Lexicon Pharmaceuticals, INC. | $15.82 | 2024 | |
| Bardy Diagnostics, INC. | $15.00 | 2020 | |
| Novo Nordisk INC | $14.50 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Fiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.